A study to assess the occurrence of metabolic diseases associated with the use of antipsychotic drugs in Korean schizophrenia patients based on the national health insurance database
- Conditions
- Mental and behavioral disorders
- Registration Number
- KCT0003568
- Lead Sponsor
- Kyung Hee University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 10000
1)Patients who were registered in the National Health Insurance database, and whose data (from the time of diagnosis to 2015) can be used for the analysis.
2)Patients who were diagnosed as schizophrenia in 2008-2010 (patients with the F20 code of International Classification of Diseases, 10th Revision (ICD-10)).
1) Patients who can not be included in the analysis due to missing information of demographics (date of birth, gender, age, etc.) diseases (i.e., name of disease), or prescription (i.e., name of prescribed drug)
2) In the case of patients who were treated with clozapine, the data cannot be included in the analysis when the information required for the analysis (e.g., drug information, average daily dose, total number of days of administration, and so on) is missing.
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Current status and trends of the use of antipsychotic drugs in schizophrenia patients
- Secondary Outcome Measures
Name Time Method se of medications for diabetes and hyperlipidemia in schizophrenia patients